original articleshematologic malignanciesFDG–PET in the assessment of patients with follicular lymphoma treated by ibritumomab tiuxetan Y 90: multicentric study
hematologic malignancies
Under an Elsevier user license
open archive
Keywords
follicular lymphoma
non-Hodgkin's lymphoma
PET
radioimmunotherapy
ibritumomab tiuxetan Y 90
Cited by (0)
Copyright © 2010 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved.